Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,307) with videos related to
Page
of 131
Sort By:
Nature Reviews. Disease Primers
|
February 2, 2023
Medication overuse headache
Sait Ashina, Gisela M Terwindt, Timothy J Steiner, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
February 18, 2025
Computational phenotyping of cognitive decline with retest learning
Zita Oravecz, Joachim Vandekerckhove, Jonathan G Hakun, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
July 26, 2021
Cerebrovascular disease hospitalizations following emergency department headache visits: A nested case-control study
Ava L Liberman, Ahmed Hassoon, Mehdi Fanai, et al.
Neurology
|
August 17, 2022
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Richard B Lipton, David W Dodick, Peter J Goadsby, et al.
Cephalalgia : an International Journal of Headache
|
June 12, 2025
Patterns of calcitonin gene-related peptide monoclonal antibody use in people with migraine: Results of the OVERCOME (US) study
Sait Ashina, Gilwan Kim, E Jolanda Muenzel, et al.
Applied Neuropsychology. Adult
|
May 31, 2021
Development and psychometric evaluation of the Test of Practical Judgment alternate form (Form B)
Crystal G Guayara-Quinn, Nadia Paré, Rachael L Scott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 29, 2023
Personality predictors of dementia diagnosis and neuropathological burden: An individual participant data meta-analysis
Emorie D Beck, Tomiko Yoneda, Bryan D James, et al.
Cephalalgia : an International Journal of Headache
|
December 1, 1993
Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated
M L Gordon, R B Lipton, S L Brown, et al.
The Lancet. Neurology
|
October 4, 2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E Bigal, David W Dodick, Alan M Rapoport, et al.
The New England Journal of Medicine
|
July 11, 2019
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
Richard B Lipton, Robert Croop, Elyse G Stock, et al.
Page
of 131
Search research articles
Search
Showing results (1121-1130 of 1,307) with videos related to
Sort By:
Page
of 131
Nature Reviews. Disease Primers
|
February 2, 2023
Medication overuse headache
Sait Ashina, Gisela M Terwindt, Timothy J Steiner, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
February 18, 2025
Computational phenotyping of cognitive decline with retest learning
Zita Oravecz, Joachim Vandekerckhove, Jonathan G Hakun, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
July 26, 2021
Cerebrovascular disease hospitalizations following emergency department headache visits: A nested case-control study
Ava L Liberman, Ahmed Hassoon, Mehdi Fanai, et al.
Neurology
|
August 17, 2022
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Richard B Lipton, David W Dodick, Peter J Goadsby, et al.
Cephalalgia : an International Journal of Headache
|
June 12, 2025
Patterns of calcitonin gene-related peptide monoclonal antibody use in people with migraine: Results of the OVERCOME (US) study
Sait Ashina, Gilwan Kim, E Jolanda Muenzel, et al.
Applied Neuropsychology. Adult
|
May 31, 2021
Development and psychometric evaluation of the Test of Practical Judgment alternate form (Form B)
Crystal G Guayara-Quinn, Nadia Paré, Rachael L Scott, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 29, 2023
Personality predictors of dementia diagnosis and neuropathological burden: An individual participant data meta-analysis
Emorie D Beck, Tomiko Yoneda, Bryan D James, et al.
Cephalalgia : an International Journal of Headache
|
December 1, 1993
Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated
M L Gordon, R B Lipton, S L Brown, et al.
The Lancet. Neurology
|
October 4, 2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E Bigal, David W Dodick, Alan M Rapoport, et al.
The New England Journal of Medicine
|
July 11, 2019
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
Richard B Lipton, Robert Croop, Elyse G Stock, et al.
Page
of 131